Autologous stem cell transplantation for refractory opsoclonus myoclonus ataxia syndrome.
Pediatr Blood Cancer. 2018 Apr 25;:e27110
Authors: Johnston DL, Murray S, Irwin MS, Doyle J, Schechter T
Abstract Opsoclonus, myoclonus, ataxia syndrome (OMA) is a severe neurologic disorder often associated with neuroblastoma. It is challenging to treat and can have long-term neurologic sequelae.